Elixxer logo

Elixxer(OTC) ELIXF

Market Cap$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-98%
1 Year+449%
1 Month+0%
$0.03
+0.00%
+0.00Today
Elixxer last closing stock price
MetricPriceDate
Last closeUSD 0.032026-05-19
Elixxer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.032026-01-23
1 month+0%USD 0.032026-01-23
3 month+0%USD 0.032026-01-23
Year to date+199.11%USD 0.012025-12-30
1 year+449.18%USD 0.012025-03-28
3 year+1.82%USD 0.032023-04-24
5 year-97.77%USD 1.502021-05-20
Since inception-99.91%USD 36.852017-12-14

Elixxer Financials at a Glance

Market Cap

$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$3.38M

EPS (TTM)

-$0.25

P/E Ratio

-0.14

Dividend

$0.00

Beta (Volatility)

-1.00 (Low)

Price

$0.03

Volume

1

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.01 - $0.10

Estimated Earnings Date

Nov 26, 2026

ELIXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elixxer

Elixxer Ltd. operates as an investment company focused on the cannabis industry, strategically deploying capital into licensed businesses engaged in the cultivation and sale of medicinal cannabis. The company has a diverse investment portfolio spanning Canada, Australia, Italy, Jamaica, and Switzerland.

Products and Services
  • Investment in fully licensed cannabis cultivation and production businesses
  • Focus on medicinal and specialized cannabis products
  • Engagement in cannabis-derived product sales for the pharmaceutical sector
Growth Outlook
  • Expansion into international markets enhances revenue potential
  • Increasing global demand for medicinal cannabis supports long-term growth
  • Strategic partnerships may lead to new investment opportunities
Financial Highlights
  • Recent quarterly net income of -$1,935,367 reflects ongoing operational challenges
  • Trailing twelve months (TTM) revenue remains at $0, indicating a need for strategic shifts
  • Current ratio of 0.0044 suggests liquidity concerns that may impact operations
Elixxer Ltd. is positioned within the growing cannabis sector, which has seen increasing demand for medicinal products. However, the company faces significant financial challenges, as indicated by its recent net income figures and lack of revenue. The current ratio highlights liquidity issues that could affect operational capabilities. Investors may find potential in the company's international expansion and strategic partnerships, but must consider the financial hurdles that need to be addressed for sustainable growth.
AI Generated • Sep 12, 2026

Industry

Capital Markets

CEO

Karim Mecklai

Headquarters

Toronto, ON M5J 2J1, CA

ELIXF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

29.06%

Return on Capital

N/A

Return on Assets

-331.68%

Earnings Yield

-7.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

95.26M

Volume

1

Avg. Volume

0

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$840.11K

EBITDA

-CA$531.09K

Operating Cash Flow

-CA$1.09M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.09M

Cash & ST Invst.

CA$37.51K

Total Debt

CA$10.54M

Elixxer Performance Analysis

Elixxer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 0N/A
20232023-12-31CAD 0N/A
20242024-12-31CAD 0N/A
20252025-12-31CAD 0N/A
Elixxer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Elixxer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.97193.0%
20232023-12-31CAD -0.26-73.1%
20242024-12-31CAD -0.22-14.8%
20252025-12-31CAD -0.249.6%
Elixxer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-27.5%
Q42025-12-31-142.9%
Q12026-03-3197.1%
Q22026-06-3024.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-CA$337.20K

+45.6%

EBITDA

CA$0.00

+100.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$37.51K

+248.6%

Total Debt

CA$10.54M

-19.9%

Accounts Receivable

CA$0.00

-100.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$10.54M

-19.9%

Return on Assets

-3.32%

N/A

Return on Invested Capital

7.82%

N/A

Free Cash Flow

-CA$228.81K

-3509.4%

Operating Cash Flow

-CA$228.81K

-3509.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DXBRFBellRock Brands Inc.
$0.00+0.00%
TCNAFTransCanna Holdings Inc.
$0.00+0.00%
FLOOFFlower One Holdings Inc.
$0.00+0.00%
SNNVFSunniva Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.08-0.54%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$147.86+0.58%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$34.41-0.72%
TQQQProShares Trust - ProShares UltraPro Qqq
$78.03+0.74%

Questions About ELIXF

What is the current price of Elixxer?

Elixxer is trading at $0.03 per share.

What is the 52-week range for Elixxer?

Over the past 52 weeks, Elixxer has traded between $0.01 and $0.10.

How much debt does Elixxer have?

As of the most recent reporting period, Elixxer reported total debt of CA$7.21M.

How much cash does Elixxer have on hand?

Elixxer reported CA$25.62K in cash and cash equivalents in its most recent financial results.

What is Elixxer’s dividend yield?

Elixxer does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.